Welcome to LookChem.com Sign In|Join Free

CAS

  • or

322405-72-1

Post Buying Request

322405-72-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

322405-72-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 322405-72-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,2,4,0 and 5 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 322405-72:
(8*3)+(7*2)+(6*2)+(5*4)+(4*0)+(3*5)+(2*7)+(1*2)=101
101 % 10 = 1
So 322405-72-1 is a valid CAS Registry Number.

322405-72-1Relevant articles and documents

Method for preparing icaritin intermediate

-

Paragraph 0085; 0091-0093, (2019/08/07)

The invention provides a method for preparing an icaritin intermediate. The method includes the steps of a, enabling phloroglucinol to react with one of a 2-benzyloxy acetylation reagent and 2-benzyloxy acetonitrile to obtain 2-benzyloxy-1-(2,4,6-trihydroxyphenyl)ethanone; b. subjecting a reaction product obtained from the step a and p-methoxybenzoyl halide to Baker-Venkataraman reaction so as toobtain 3-(benzyloxy)-5,7-dihydroxy-2-(4-methoxyphenyl)-4H-benzopyran-4-one; c. subjecting the reaction product obtained in the step b to hydrogenation so as to obtain the icaritin intermediate, namely 3,5,7-trihydroxy-2-(4-methoxyphenyl)-4H-benzopyran-4-one.

Total synthesis of acetylcholinesterase inhibitor macakurzin C

Lee, Dongjoo,Shin, Iljin,Ko, Eunjae,Lee, Kiyoun,Seo, Seung-Yong,Kim, Hyoungsu

, p. 2794 - 2796 (2015/01/09)

A concise total synthesis of macakurzin C has been accomplished in nine steps (21% overall yield) from commercially available phloroglucinol, featuring a sequential aromatic Claisen rearrangement-cyclization.

BENZOPYRONE ESTROGEN RECEPTOR REGULATOR

-

Paragraph 0288, (2013/11/19)

The present invention provides a kind of benzopyrone compounds having a structure of formula (I) and the pharmaceutically acceptable salts or prodrugs thereof, and the pharmaceutical compositions containing such compounds, which can be used to regulate the novel estrogen receptor ER-a36, and prevent and/or treat the related diseases mediated by the ER-a36 receptor, such as cancers, etc.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 322405-72-1